The level of MnSOD is directly correlated with grade of brain tumours of neuroepithelial origin

British Journal of Cancer

Volumn 74, Issue 12, 1996, Pages 1877-1885

  Landriscina, M ^a   Remiddi, F ^a   Ria, F ^a   Palazzotti, B ^a   De Leo, M E ^a   Iacoangeli, M ^b   Rosselli, R ^b   Scerrati, M ^b   Galeotti, T ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Brain tumour; MnSOD; Progression; Tumour grading; Tumour suppressor gene

Indexed keywords

MANGANESE SUPEROXIDE DISMUTASE;

ADOLESCENT; ADULT; AGED; ARTICLE; BRACHYTHERAPY; BRAIN TUMOR; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOLOGY; MALE; NEUROEPITHELIOMA; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; TUMOR DIFFERENTIATION;

EID: 0030444002     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.648     Document Type: Article

References (31)

1. BRAVARD A, SABATIER L, HOFFSCHIR F, RICOUL M, LUCCIONI C AND DUTRITLLAUX D. (1992a). SOD2: a new type of tumor-suppressor gene? Int. J. Cancer, 51, 476-480.
2. BRAVARD A, HOFFSCHIR F, SABATIER L, RICOUL M, PINTON A, CASSINGENA R, ESTRADE S, LUCCIONI C AND DUTRILLAUX D. (1992b). Early superoxide dismutation alteration during SV40-transformation of human fibroblasts. Int. J. Cancer, 52, 797-801.
3. CHROMEZYNSKI P AND SACCHI N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate phenol chloroform extraction. Anal. Biochem., 162, 156-159.
4. CHURCH SL, GRANT JW, RIDNOUR LA, OBERLEY LW, SWANSON PE, MELTZER PS AND TRENT JM. (1993). Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. Proc. Natl Acad. Sci. USA, 90, 3113-3117.
5. FRANZINI A, LEOCATA F, CAJOLA L, SERVELLO D, ALLEGRANZA A AND BROGGI G. (1994). Low-grade glial tumors in basal ganglia and thalamus: natural history and biological reappraisal. Neurosurgery, 35, 817-821.
6. FULTS D, BROCKMEYER D, TULLOUS MW, PEDONE CA AND CAWTHON RM. (1992). p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res., 52, 674-679.
7. GALEOTTI T, WOHLRAB H, BORRELLO S AND DE LEO ME. (1989). Messenger RNA for manganese and copper-zinc superoxide dismutases in hepatomas: correlation with degree of differentiation. Biochem. Biophys. Res. Commun., 165, 581-589.
8. GALEOTTI T, PALOMBINI G AND VAN ROSSUM GD. (1995). Manganese content and high-affinity transport in rat liver and hepatocarcinoma. Arch. Biochem. Biophys., 322, 453-459.
9. HARRIS ED. (1992). Regulation of antioxidant enzymes. FASEB J., 6, 2675-2683.
10. HASSAN HM. (1988). Biosynthesis and regulation of superoxide dismutase. Free Rad. Biol. Med., 5, 377-385.
11. HURTT MR, MOOSSY J, DONOVAN-PELUSO M AND LOCKER J. (1992). Amplification of epidermal growth factor receptor gene in gliomas: histopathology and prognosis. J. Neuropathol. Exp. Neurol., 51, 84-90.
12. IIZUKA S, TANIGUCHI N AND MAKITA A. (1984). Enzyme-linked immunosorbent assay for human manganese-containing superoxide dismutase and its content in lung cancer. J. Natl Cancer Inst., 72, 1043-1048.
13. ISHIKAWA M, YAGINUMA Y, HAYASHI H, SHIMIZU T, ENDO Y AND TANIGUCHI N. (1990). Reactivity of a monoclonal antibody to manganese superoxide dismutase with human ovarian carcinoma. Cancer Res., 50, 2538-2542.
14. KAWAGUCHI T, NOJI S, UDA T, NAKASHIMA Y, TAKEYASU A, KAWAI Y, TAGAKI H, TOHYAMA M AND TANIGUCHI N. (1989). A monoclonal antibody against COOH-terminal peptide of human liver manganese superoxide dismutase. J. Biol. Chem., 264, 5762-5767.
15. KAWAMURA N, SUZUKI K, ISHIKAWA M, IIZUKA S, MIYAKE M, MINO M AND TANIGUCHI N. (1992). High levels of Mn-superoxide dismutase in serum of patients with neuroblastoma and in human neuroblastoma cell lines. Free Rad. Biol. Med., 12, 281-286.
16. KORKOLOPOULOU P, CHRISTODOULO P, PAPANIKOLAOU A AND THOMAS-TSAGLI E. (1993). Proliferating cell nuclear antigen and nucleolar organizer regions in CNS tumors: correlation with histological type and tumor grade. Am. J. Surg. Pathol., 17, 912-919.
17. LABROUSSE F, DAUMAS-DUPORT C, BATORSKI L AND HOSHINO T. (1991). Histological grading and bromodeoxyuridine labeling index of astrocytomas. Comparative study in a series of 60 cases. J. Neurosurg., 75, 202-205.
18. LI JJ, OBERLEY LW, ST-CLAIR DK, RIDNOUR LA AND OBERLEY TD. (1995). Phenotypic changes induced in human breast cancer cells by overexpression of manganese-containing superoxide dismutase. Oncogene, 10, 1989-2000.
19. LING GN, KOLEBIC T AND DAMADIEN R. (1990). Low paramagnetic-ion content in cancer cells: its significance in cancer detection by magnetic resonance imaging. Physiol. Chem. Phys. Med. MNR, 22, 1-14.
20. MARTIN JP, DAILEY M AND SURGEMAN E. (1987). Negative and positive assays of superoxide dismutase based on hematoxylin autoxidation. Arch. Biochem. Biophys., 255, 329-336.
21. MORIMURA T, KITZ K, STEIN H AND BUDKA H. (1991). Determination of proliferative activities in human brain tumor specimens: a comparison of three methods. J. Neurooncol., 10, 1-11.
22. NITTA T, EBATO M, SATO K AND OKUMURA K. (1994). Expression of tumour necrosis factor-α, -β and interferon-γ genes within human neuroglial tumour cells and brain specimens. Cytokine, 6, 171-180.
23. RASHEED BK, MCLENDON RE, HERNDON JE, FRIEDMAN AH, BIGNER DD AND BIGNER SH. (1994). Alterations of the TP53 gene in human gliomas. Cancer Res., 54, 1324-1330.
24. RIA F, LANDRISCINA M AND GALEOTTI T. (1993). Preparation of a monoclonal antibody against rat MnSOD, using a COOH-terminal peptide. Biochem. Biophys. Res. Commun., 195, 697-703.
25. RIA F, LANDRISCINA M, REMIDDI F AND GALEOTTI T. (1994). Monoclonal antibody 35.8 recognizes human, mouse and rat MnSOD in western blot and immunostaining. Biochem. Mol. Biol. Int., 33, 107-115.
26. RITLAND SR, GANIU V AND JENKINS RB. (1995). Region specific-loss of heterozygosity on chromosome 19 is related to the morphologic type of human glioma. Genes Chrom. Cancer, 12, 277-282.
27. ROSEMAN BJ, BOLLEN A, HSU J, LAMBORN K AND ISRAEL MA. (1994). Annexin II marks astrocytic brain tumors of high histologic grade. Oncol. Res., 6, 561-567.
28. SCHLEGEL J, STUMM G, BRANDLE K, MERDES A, MECHTERSHEIMER G, HYNES NE AND KIESSLING M. (1994). Amplification and differential expression of members of the erhB-gene family in human glioblastoma. J. Neurooncol., 22, 201-207.
29. SUN Y. (1990). Free radicals, antioxidant enzymes and carcinogenesis. Free Rad. Biol. Med., 8, 583-599.
30. VON DEIMLING A, EIBL RH, OHGAKI H, LOUIS DN, VON AMMON K, PETERSEN I, KLEIHUES P, CHUNG RY, WIESTLER OD AND SEIZINGER BR. (1992). p53 mutation are associated with 17p allelic loss in grade II and grade III astrocytomas. Cancer Res., 52, 2987-2990.
31. WONG GH. (1995). Protective roles of cytokines against radiation: induction of mitochondrial MnSOD. Biochim. Biophys. Acta, 1271, 205-209.